Literature DB >> 23356984

Glucocorticoids and osteocyte autophagy.

Wei Yao1, Weiwei Dai, Jean X Jiang, Nancy E Lane.   

Abstract

Glucocorticoids are used for the treatment of inflammatory and autoimmune diseases. While they are effective therapy, bone loss and incident fracture risk are high. While previous studies have found GC effects on both osteoclasts and osteoblasts, our work has focused on the effects of GCs on osteocytes. Osteocytes exposed to low dose GCs undergo autophagy while osteocytes exposed to high doses of GCs or for a prolonged period of time undergo apoptosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356984      PMCID: PMC3784314          DOI: 10.1016/j.bone.2013.01.034

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  82 in total

1.  Bone as a source of FGF23: regulation by phosphate?

Authors:  Michiko Mirams; Bruce G Robinson; Rebecca S Mason; Anne E Nelson
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

Review 2.  Another way to die: autophagic programmed cell death.

Authors:  Y Tsujimoto; S Shimizu
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

3.  Mechanosensation and Transduction in Osteocytes.

Authors:  Lynda F Bonewald
Journal:  Bonekey Osteovision       Date:  2006-10

Review 4.  The osteocyte lineage.

Authors:  Brendon S Noble
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

5.  The spontaneous shedding of the lymphocyte receptor for sheep red blood cells.

Authors:  L A Fernandez; J M Macsween
Journal:  Dev Comp Immunol       Date:  1977-10       Impact factor: 3.636

6.  Cytoplasmic shedding as a mode of formation of lymphocyte- like blast cells by newt histiocytes.

Authors:  E G Rondanelli; E Magliulo; G Carosi; D Dionisi
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

7.  Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner.

Authors:  Elisheva Smith; Baruch Frenkel
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

Review 8.  Glucocorticoid-induced osteoporosis: an update.

Authors:  Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Journal:  Trends Endocrinol Metab       Date:  2006 May-Jun       Impact factor: 12.015

9.  FGF23 is a putative marker for bone healing and regeneration.

Authors:  Sascha Goebel; Jasmin Lienau; Ulrich Rammoser; Lothar Seefried; Karl Florian Wintgens; Jochen Seufert; Georg Duda; Franz Jakob; Regina Ebert
Journal:  J Orthop Res       Date:  2009-09       Impact factor: 3.494

10.  Serum FGF23 levels in normal and disordered phosphorus homeostasis.

Authors:  Thomas J Weber; Shiguang Liu; Olafur S Indridason; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

View more
  13 in total

Review 1.  Autophagy as a target for glucocorticoid-induced osteoporosis therapy.

Authors:  Gengyang Shen; Hui Ren; Qi Shang; Ting Qiu; Xiang Yu; Zhida Zhang; Jinjing Huang; Wenhua Zhao; Yuzhuo Zhang; Xiaobing Jiang
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

Review 2.  The Osteocyte: New Insights.

Authors:  Alexander G Robling; Lynda F Bonewald
Journal:  Annu Rev Physiol       Date:  2020-02-10       Impact factor: 19.318

Review 3.  Skeletal Aging.

Authors:  Jad G Sfeir; Matthew T Drake; Sundeep Khosla; Joshua N Farr
Journal:  Mayo Clin Proc       Date:  2022-06       Impact factor: 11.104

4.  Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.

Authors:  W Yao; W Dai; L Jiang; E Y-A Lay; Z Zhong; R O Ritchie; X Li; H Ke; N E Lane
Journal:  Osteoporos Int       Date:  2015-09-18       Impact factor: 4.507

5.  Parathyroid hormone as a marker for metabolic bone disease of prematurity.

Authors:  A Moreira; L Swischuk; M Malloy; D Mudd; C Blanco; C Geary
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

Review 6.  Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.

Authors:  Nancy E Lane
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

Review 7.  Connexin Gap Junctions and Hemichannels Link Oxidative Stress to Skeletal Physiology and Pathology.

Authors:  Rui Hua; Jingruo Zhang; Manuel A Riquelme; Jean X Jiang
Journal:  Curr Osteoporos Rep       Date:  2021-01-06       Impact factor: 5.096

8.  Glucocorticoids Suppress Antimicrobial Autophagy and Nitric Oxide Production and Facilitate Mycobacterial Survival in Macrophages.

Authors:  Jinli Wang; Ruining Wang; Hui Wang; Xiaofan Yang; Jiahui Yang; Wenjing Xiong; Qian Wen; Li Ma
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

9.  Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis.

Authors:  A Karunaratne; L Xi; L Bentley; D Sykes; A Boyde; C T Esapa; N J Terrill; S D M Brown; R D Cox; R V Thakker; H S Gupta
Journal:  Bone       Date:  2015-12-02       Impact factor: 4.398

10.  Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes.

Authors:  Junjie Gao; Tak Sum Cheng; An Qin; Nathan J Pavlos; Tao Wang; Kai Song; Yan Wang; Lianzhi Chen; Lin Zhou; Qing Jiang; Hiroshi Takayanagi; Sheng Yan; Minghao Zheng
Journal:  Oncotarget       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.